Amid Monkeypox Worry, What Adar Poonawalla Said On Making Vaccine

Adar Poonawalla said that the Serum Institute of India (SII) is in talks with Novovax to develop a messenger RNA (mRNA) vaccine for monkeypox.

Live TV
Top News
Latest
COVID-19
India
Videos
Opinion
World
Cities
Shopping
Offbeat
Photos
Trending
Sports
South
Jobs
People
Weather
TV Schedule
Science
Web Stories
हिंदी
Tech News
Auto
Swirlster
Health
Movies
Apps
Trains
Trending Stories
1
Opinion: The Reason Why Eknath Shinde's MLAs Are Now Spamming Him
2
Madhya Pradesh Couple Torture Adopted Daughter For Bed-Wetting, Arrested
3
Spectacular Video Shows Massive Fireball Lighting Up Night Sky Over US
4
On Camera, Congress Leader's Hair Pulled, Delhi Cops Manhandle Him
5
Student Found Dead On Railway Tracks, Mystery Message Sent From Phone
6
Rahul Gandhi Detained During Protest: "Modi-ji Is King, Police State"
7
Russia To Quit International Space Station "After 2024"
8
19 Rajya Sabha MPs Suspended Day After Action Against 4 Lok Sabha MPs
9
India Slams China, Pak Move To Involve 3rd Nations In Project Through PoK
10
Monkeypox Has Been A "Wake-Up Call", Says WHO Chief Scientist
View More Stories
HomeAll IndiaAmid Monkeypox Worry, What Adar Poonawalla Said On Making Vaccine
Amid Monkeypox Worry, What Adar Poonawalla Said On Making Vaccine
Adar Poonawalla said that the Serum Institute of India (SII) is in talks with Novovax to develop a messenger RNA (mRNA) vaccine for monkeypox.
ADVERTISEMENT

All India Reported by Vishnu Som, Edited by Deepshikha Ghosh
Updated : July 26, 2022 5:34 pm IST

New Delhi: Amid worries over four monkeypox cases in India, vaccine-maker Adar Poonawalla said today that the Serum Institute of India is spending its own funds to import a few million doses of a Danish smallpox vaccine which can be used to treat cases if there is a larger breakout of the infection in India.
The initial consignment of the small pox vaccine, manufactured by the Danish company Bavarian Nordic, could be here in a few months once a contract is signed.

"We are talking to them...That's a decision the government of India will eventually have to make with the experts - should we, like other nations, start stockpiling a small quantity, just a few million doses of the vaccine. I am prepared to import it at risk at my cost, initially, in small volumes. Eventually, the government will have to decide on a health policy," Mr Poonawalla said.

The Serum Institute of India would also be in a position to eventually procure the vaccine in bulk quantities should it be required before bottling it and marketing it around the world while ensuring that India's requirements are met.

"In an emergency situation, we could always do the full finish of the product made by that company. That would give access to Indians without safety issues - since the vaccine is time-tested. To make it from scratch will take some time. Bulk supply should be adequate to handle," Mr Poonawalla said.

There have not been any formal talks with the government of India yet on the large-scale supply of the smallpox vaccine since only a handful of Monkeypox cases have been reported in India so far. While no costs have been decided yet, Mr Poonawalla says the drug will be made as affordable as possible.

At the same time, the Serum Institute is exploring the development of a new Messenger RNA (mRNA) vaccine for monkeypox along with Novavax, one of its global partners.

In theory, he said, it could take more than a year to make a vaccine from scratch.

"As a vaccine manufacturer equipped with technological knowhow, we are looking at talking to partners. We are talking to Novovax. We really need to see whether there will be a lot of demand or whether in three to four months it fizzles out," Mr Poonawalla said.

He said it was "not a mystery" that monkeypox cases were coming up. "It has been around for decades," he said. The only difference was that the global health system was more trained and equipped to detect and tackle infectious diseases.

The Serum Institute manufacturers Covishield, the Indian version of the Oxford-Astrazeneca Covid vaccine in addition to host of other life-saving vaccines which it exports around the world.